46. Malignant rheumatoid arthritis
4,183 clinical trials,   2,538 drugs   (DrugBank: 401 drugs),   183 drug target genes,   219 drug target pathways
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01179971 (ClinicalTrials.gov) | December 2008 | 4/8/2010 | n-3 and n-6 Fatty Acids in Rheumatoid Arthritis | Incorporation of n-3 Long Chain Polyunsaturated Fatty Acids and Gamma Linolenic Acid in Plasma Lipids, Cholesteryl Esters, and Erythrocyte Membranes and Their Influence on Disease Activity in Patients With Rheumatoid Arthritis | Rheumatoid Arthritis | Dietary Supplement: Fish oil, gamma-linolenic acid | Charite University, Berlin, Germany | University of Jena | Completed | 18 Years | 80 Years | Both | 60 | Phase 2 | NULL |
2 | NCT00004420 (ClinicalTrials.gov) | September 1994 | 18/10/1999 | Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis | Juvenile Rheumatoid Arthritis | Drug: gamma-Linolenic acid | FDA Office of Orphan Products Development | University of Massachusetts, Worcester | Completed | 1 Year | 15 Years | Both | 50 | N/A | NULL |